[HTML][HTML] Advancements in 3D cell culture systems for personalizing anti-cancer therapies
AMK Law, L Rodriguez de la Fuente, TJ Grundy… - Frontiers in …, 2021 - frontiersin.org
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
[HTML][HTML] Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
AMK Law, LR de la Fuente, TJ Grundy, G Fang… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies.
AMK Law, TJ Grundy, G Fang, F Valdes-Mora… - Frontiers in …, 2021 - europepmc.org
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
Rodriguez de la Fuente L, Grundy TJ, Fang G, Valdes-Mora F and Gallego-Ortega D (2021) Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer …
AMK Law - Drug Resistance in Breast Cancer–Mechanisms and …, 2023 - books.google.com
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
AMK Law, LR de la Fuente, TJ Grundy… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies.
AMK Law, L Rodriguez de la Fuente, TJ Grundy… - Front …, 2021 - opus.lib.uts.edu.au
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
[PDF][PDF] Rodriguez de la Fuente L, Grundy TJ, Fang G, Valdes-Mora F and Gallego-Ortega D (2021) Advancements in 3D Cell Culture Systems for Personalizing Anti …
AMK Law - Oncol, 2021 - opus.lib.uts.edu.au
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …
trials. The main reason for this failure can be attributed to the non-accurate pre-clinical …